Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet von Willebrand factor.

H R Gralnick1, S B Williams, L P McKeown

  • 1Hematology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland.

Mayo Clinic Proceedings
|June 1, 1991
PubMed
Summary

Platelet von Willebrand factor (vWF) is crucial for controlling bleeding in von Willebrand

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.

Urologic oncology·2022
Same author

COVID-19's Social Ecological Impacts on Health and Human Services Worker Well-being.

Social work in public health·2021
Same author

Environment-wide association study to comprehensively test and validate associations between nutrition and lifestyle factors and testosterone deficiency: NHANES 1988-1994 and 1999-2004.

Hormones (Athens, Greece)·2020
Same author

Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer.

Prostate cancer and prostatic diseases·2017
Same author

Triple bag hermetic technology for controlling a bruchid (<i>Spermophagus</i> sp.) (Coleoptera, Chrysomelidae) in stored <i>Hibiscus sabdariffa</i> grain.

Journal of stored products research·2016
Same author

Robot assisted radical prostatectomy: the new standard?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2014

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Biology

Background:

  • Von Willebrand factor (vWF) exists in plasma and platelets.
  • Platelet vWF, stored in alpha granules, is critical for bleeding in von Willebrand's disease (vWD).

Purpose of the Study:

  • To investigate the role and mechanisms of platelet von Willebrand factor (vWF) in hemostasis and thrombosis.
  • To elucidate the contribution of platelet vWF to bleeding time and clinical severity in vWD.

Main Methods:

  • Analysis of platelet vWF release and surface expression.
  • Inhibition studies using fibrinogen, monoclonal antibodies, aspirin, and cytoskeleton disruption.
  • Evaluation of transfusion effects on bleeding time in vWD.

Main Results:

  • Platelet vWF release is modulated by agonists and inhibited by specific agents.
  • Aspirin significantly reduces adenosine diphosphate-induced platelet vWF expression.
  • Platelet vWF is essential for correcting bleeding time in severe vWD, indicating dual roles of plasma and platelet vWF.

Conclusions:

  • Platelet vWF is hypothesized to be vital for platelet adhesion and spreading on subendothelial surfaces under high shear stress.
  • Platelet vWF acts as a bridge, initiating platelet spreading and promoting aggregation, crucial for hemostasis and thrombosis.

Related Experiment Videos